No summary has been written for this.
Roundhill GLP-1 & Weight Loss ETF is an actively managed exchange-traded fund focused on companies involved in GLP-1 therapies and broader weight management solutions. The fund is designed to provide concentrated exposure to pharmaceutical and biotechnology businesses developing, commercializing, or supporting treatments for obesity and related metabolic conditions. Its portfolio can also include derivative instruments tied to companies in this theme, allowing the strategy to capture a wider range of market participants across the weight-loss drug ecosystem. Roundhill GLP-1 & Weight Loss ETF serves investors seeking targeted access to one of the most closely watched healthcare segments, linking the growth of weight management innovation with the public markets. The fund is part of Roundhill Investments’ thematic ETF lineup and is structured to reflect a specialized view of the global healthcare and pharmaceutical landscape.
No summary yet.
No summary yet.
No summary yet.
No summary yet.
No summary yet.
Investors talking about OZEM also mention these. Each card shows that asset’s own numbers for the past 24 hours.